These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tapentadol-ER for the treatment of diabetic peripheral neuropathy. Games G; Hutchison A Consult Pharm; 2013 Oct; 28(10):672-5. PubMed ID: 24129223 [TBL] [Abstract][Full Text] [Related]
3. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice. Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022 [TBL] [Abstract][Full Text] [Related]
4. Tapentadol for pain: a treatment evaluation. Hartrick CT; Rodríguez Hernandez JR Expert Opin Pharmacother; 2012 Feb; 13(2):283-6. PubMed ID: 22192161 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697 [TBL] [Abstract][Full Text] [Related]
6. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Niesters M; Proto PL; Aarts L; Sarton EY; Drewes AM; Dahan A Br J Anaesth; 2014 Jul; 113(1):148-56. PubMed ID: 24713310 [TBL] [Abstract][Full Text] [Related]
7. Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor. Hartrick CT; Rozek RJ CNS Drugs; 2011 May; 25(5):359-70. PubMed ID: 21476608 [TBL] [Abstract][Full Text] [Related]
8. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Christoph T; De Vry J; Tzschentke TM Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182 [TBL] [Abstract][Full Text] [Related]
9. The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout mice. Kögel B; De Vry J; Tzschentke TM; Christoph T Neurosci Lett; 2011 Mar; 491(2):104-7. PubMed ID: 21232580 [TBL] [Abstract][Full Text] [Related]
11. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain. Schröder W; Vry JD; Tzschentke TM; Jahnel U; Christoph T Eur J Pain; 2010 Sep; 14(8):814-21. PubMed ID: 20541444 [TBL] [Abstract][Full Text] [Related]
12. Is tapentadol an advance on tramadol? Guay DR Consult Pharm; 2009 Nov; 24(11):833-40. PubMed ID: 20092221 [TBL] [Abstract][Full Text] [Related]
13. Unique pharmacology of tapentadol for treating acute and chronic pain. Knezevic NN; Tverdohleb T; Knezevic I; Candido KD Expert Opin Drug Metab Toxicol; 2015; 11(9):1475-92. PubMed ID: 26215077 [TBL] [Abstract][Full Text] [Related]
14. [Tapentadol. Opioid analgesic and norepinephrine reuptake inhibitors]. Weichel C; Hecht B Med Monatsschr Pharm; 2010 Dec; 33(12):454-60. PubMed ID: 21189520 [No Abstract] [Full Text] [Related]
15. Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain. Merchant S; Noe LL; Howe A; Duff S; Gricar J; Ogden K; Mody SH Clin Ther; 2013 May; 35(5):659-72. PubMed ID: 23587608 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of tapentadol metabolites. Terlinden R; Kogel BY; Englberger W; Tzschentke TM Methods Find Exp Clin Pharmacol; 2010; 32(1):31-8. PubMed ID: 20383344 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of tapentadol ER for managing moderate to severe chronic pain. Afilalo M; Morlion B Pain Physician; 2013 Jan; 16(1):27-40. PubMed ID: 23340531 [TBL] [Abstract][Full Text] [Related]
19. A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy. Schwartz S; Etropolski MS; Shapiro DY; Rauschkolb C; Vinik AI; Lange B; Cooper K; Van Hove I; Haeussler J Clin Drug Investig; 2015 Feb; 35(2):95-108. PubMed ID: 25503082 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology update: tapentadol for neuropathic pain. Pierce DM; Shipstone E Am J Hosp Palliat Care; 2012 Dec; 29(8):663-6. PubMed ID: 22310021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]